SEC Form 4 · accession 0001140361-17-018657
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Rebecca M Henderson
Director
Period of report
May 3, 2017
Accepted (ET)
May 5, 2017 · 6:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 4, 2017 | M | 6,602 | $38.795 | A | 21,552 | D | |
| Common StockF1 | May 4, 2017 | S | 1,700 | $159.9485 | D | 19,852 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Stock UnitF5,F2 | — | May 3, 2017 | A | 289 | A | — | — | Common Stock | 289 | 17,094 | D |
| Non-Qualified Stock Option (right-to-buy)F5,F3 | $160.28 | May 3, 2017 | A | 3,046 | A | — | May 2, 2027 | Common Stock | 3,046 | 3,046 | D |
| Non-Qualified Stock Option (right-to-buy)F5,F4 | $38.795 | May 4, 2017 | M | 6,602 | D | — | Feb 13, 2018 | Common Stock | 6,602 | 0 | D |
Explanation of responses
- F1Represents the weighted average sales price of the shares sold ranging from a low of $159.9110 to a high of $159.9718 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F2Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2018 annual meeting of stockholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors.
- F3Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on May 3, 2018.
- F4Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 3,301 shares on February 14, 2012, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split").? The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.
- F5Not applicable.